Form 4 for LLY Lilly (Eli)
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-13 · accession 0000059478-25-000218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-13 | 2025-08-13 | LLY | Van Naarden Jacob | EVP, Pres, Lilly Oncology | P - Purchase | $647.36 | +1,000 | 20.6K | +5% | +$647.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-13 | P | A | 1,000 | $647.36 | 20,561.99 | D | — | — |